Status:
COMPLETED
Intravenous Lidocaine for Fibromyalgia
Lead Sponsor:
Federal University of São Paulo
Conditions:
Fibromyalgia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The effect of intravenous lidocaine infusion on manifestations of fibromyalgia manifestations were recorded before and 4 weeks after treatment. Pain intensity was rated on a numerical scale.The combin...
Detailed Description
Thirty patients ranging in age from 18 to 60 years, with fibromyalgia (American College of Rheumatology criteria: pain in the four quadrants of the body for at least 3 months and a minimum of 11 out o...
Eligibility Criteria
Inclusion
- 18 to 60 years, with fibromyalgia (American College of Rheumatology criteria: pain in the four quadrants of the body for at least 3 months and a minimum of 11 out of 18 tender points
Exclusion
- Thyroid, rheumatological, renal and hepatic function
- Trauma
- Rheumatic, neuromuscular or psychiatric disease
- Infectious arthropathy
- Other pain syndromes
- Drug hypersensitivity; AND
- Pregnancy
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00986505
Start Date
February 1 2005
End Date
December 1 2007
Last Update
September 30 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.